Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Cost of Revenue (2023 - 2025)

Historic Cost of Revenue for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $302.7 million.

  • Guardian Pharmacy Services' Cost of Revenue rose 1940.36% to $302.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1876.94%. This contributed to the annual value of $984.0 million for FY2024, which is 1744.34% up from last year.
  • According to the latest figures from Q3 2025, Guardian Pharmacy Services' Cost of Revenue is $302.7 million, which was up 1940.36% from $276.2 million recorded in Q2 2025.
  • Guardian Pharmacy Services' 5-year Cost of Revenue high stood at $302.7 million for Q3 2025, and its period low was $210.5 million during Q3 2023.
  • Moreover, its 3-year median value for Cost of Revenue was $253.5 million (2024), whereas its average is $251.7 million.
  • In the last 5 years, Guardian Pharmacy Services' Cost of Revenue surged by 2040.67% in 2024 and then surged by 1568.13% in 2025.
  • Guardian Pharmacy Services' Cost of Revenue (Quarter) stood at $226.5 million in 2023, then rose by 19.86% to $271.5 million in 2024, then increased by 11.51% to $302.7 million in 2025.
  • Its Cost of Revenue was $302.7 million in Q3 2025, compared to $276.2 million in Q2 2025 and $265.0 million in Q1 2025.